Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bacterial sensitivity to the aminoglycosides.

C H Clark

    Modern Veterinary Practice
    |August 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Gentamicin exhibits broad-spectrum antibacterial activity with limited resistance, making it a key aminoglycoside. Streptomycin shows rapid resistance development, limiting its effectiveness in animal disease treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Establishing a National SABR Service: A Model for Safe and Effective Clinical Implementation.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2025
    Same author

    European Society of Radiotherapy and Oncology (ESTRO) strategy 2024-2026: Growth and diversification in a rapidly changing world.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2024
    Same author

    Development of a heterogeneous phantom to measure range in clinical proton therapy beams.

    Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2021
    Same author

    An end-to-end assessment on the accuracy of adaptive radiotherapy in an MR-linac.

    Physics in medicine and biology·2021
    Same author

    Comparing Proton to Photon Radiotherapy Plans: UK Consensus Guidance for Reporting Under Uncertainty for Clinical Trials.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2020
    Same author

    Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2019

    Area of Science:

    • Microbiology
    • Pharmacology
    • Veterinary Medicine

    Background:

    • Bacterial infections pose significant challenges in human and animal health.
    • Aminoglycosides are a crucial class of antibiotics used to combat bacterial pathogens.
    • Understanding the spectrum of activity and resistance patterns of aminoglycosides is vital for effective treatment.

    Purpose of the Study:

    • To review and summarize the bacterial sensitivity testing data for commonly used aminoglycosides.
    • To compare the efficacy of gentamicin, amikacin, tobramycin, streptomycin, and neomycin against various bacterial species.
    • To identify the most effective aminoglycosides and highlight potential resistance issues.

    Main Methods:

    • Review of existing reports on bacterial sensitivity testing.

    Related Experiment Videos

  • Analysis of antibiotic efficacy data against specific bacterial genera.
  • Assessment of resistance prevalence for each aminoglycoside.

    • Main Results:

    • Gentamicin demonstrates broad-spectrum activity with few resistant organisms.
    • Gentamicin, amikacin, and tobramycin are highly effective against Pseudomonas, Escherichia, salmonellae, staphylococci, pasteurellae, and Klebsiella.
    • Streptomycin's efficacy is limited by rapid resistance development, particularly in animal diseases.
    • Neomycin shows moderate effectiveness against staphylococci and gram-negative intestinal organisms but is less effective against streptococci.

    Conclusions:

    • Gentamicin is a highly effective aminoglycoside with a broad spectrum of activity and low resistance rates.
    • Amikacin and tobramycin are also potent against key pathogens like Pseudomonas.
    • Streptomycin's utility is compromised by rapid resistance, making it less effective.
    • Neomycin has a more limited but useful spectrum against specific gram-negative and staphylococcal infections.